Pharmaceutical Technology Europe, Nov 1, 2011 - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

Pharmaceutical Technology Europe, Nov 1, 2011
Editor's Comment
Jobs and Innovation
By Rich Whitworth
The middle word in our magazine's title is technology, so I cannot fail to join the increasing numbers of people in all fields of business commenting on the passing of Steve Jobs.
Special Feature
What's on the Box?
By Stephen Kemp
Counterfeiting continues to be a huge challenge affecting both branded and generic products, which, although a worldwide issue, is especially prominent in developing countries.
EFPIA for Greater Patient Safety
Counterfeit medicines are an increasing threat to the EU supply chain and there is need for a standard identification solution across Europe.
Europe Prepares To Battle The Counterfeiters
In an age dominated by the internet and uncertainty over the best packaging security methods to employ, counterfeit medicines have the ideal environment to thrive.
Applying Universal Anticounterfeiting Technologies
By Mark Davison
It is very difficult to measure the problem of counterfeiting accurately from year to year; by definition criminals don?t file tax returns or publish quarterly earnings.
Ensuring Compliance With Code Readability
PTE interviews Leigh Jordan, UK Sales Manager at Cognex UK Ltd, about the importance of code readability when using anticounterfeiting solutions such as 2D datamatrix codes.
Optical Character Recognition and Code Verification
By Kyle O'Brien
Inspection systems play a big part in ensuring product quality.
The Advantages Of A Web-Based System
By Dr. Fred Jordan
Dr. Fred Jordan, CEO at AlpVision SA, explains how web-based server solutions can aid anticounterfeiting strategies and why such systems are seeing increased uptake.
Industry Insider
Threats and Opportunities in Cardiovascular Health
By Nathan Jessop
With the cardiovascular disease burden in Europe increasing, policymakers, regulators and other healthcare stakeholders are seeking to raise awareness and lessen the threat.
Ask the Expert
Under Continuous Consideration
By Tim Freeman
Continuous manufacturing is increasingly noted as an important long-term objective for the pharmaceutical industry. PTE talks with Tim Freeman, Director of Operations at Freeman Technology, about some of the central issues involved in this transition, as well as the supporting role of relevant analytical technology.
Disposables Advisor
Focus on Standardisation, Quality by Design and Regulatory GMP
By Jerold Martin
June and July saw three major US conferences on implementing single-use technologies: the IBC Single-use Applications meeting, the PDA Single-use Workshop and the Bio-Process Systems Alliance (BPSA) International Single-use Summit (ISUS). Jerold Martin highlights some of the key topics discussed at these meetings.
By Stephanie Sutton
EC wants clear rules for medicines information


LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
Click here